Suraksha Diagnostic reported 22.5% YoY revenue growth to ₹3,135.78 million for FY26 with 15.8% EBITDA growth.
Q4 FY26 PAT declined 14.1% YoY to ₹61.59 million despite 24.7% revenue growth to ₹821.97 million.
Company expanded operations by adding 2 hubs, 11 spoke centers and 4 PPP facilities during FY26.
Management highlighted investments in new centers impacted margins while mature centers maintain 36-37% EBITDA margins.